pentobarbital will decrease the extent or impact of bedaquiline by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Prevent or Use Alternate Drug. Steer clear of coadministration of bedaquiline with powerful CYP3A4 inducers because of possible for decreased therapeutic outcomepentobarbital will lower the level or outcome of etonogestrel by